American Journal of Internal Medicine

| Peer-Reviewed |

First European Case of TAFRO Syndrome Associated with Sjogren Disease

Received: 03 July 2014    Accepted: 05 November 2014    Published: 20 November 2014
Views:       Downloads:

Share This Article

Abstract

We herein describe a case of an unusual multicentric castleman disease(MCD) accompanied by Thrombocytopenia, Anasarca, myeloFibrosis and Renal failure, compatible with TAFRO syndrome and associated with Sjogren disease. The treatment with corticosteroids dramatically improved the symptoms. The clinical features of this case were similar to those reported previously in Japan but this appears to be the first European MCD with negative HHV8 and HIV that meets the criteria of TAFRO syndrome, associated with Sjögren disease.

DOI 10.11648/j.ajim.20140206.12
Published in American Journal of Internal Medicine (Volume 2, Issue 6, November 2014)
Page(s) 102-105
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

TAFRO Syndrome, Sjogren Disease, Castleman Disease, Interleukin-6, Thrombocytopenia, Pleural Effusion

References
[1] Takai K, Nikkuni K, Shibuya H, Hashidate H: Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51:320-325, 2010 (in Japanese)
[2] Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, et al.: Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20:44-50, 2011
[3] Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyper-plasia resembling thymona. Cancer 1956; 9:822-30.
[4] Frizzera G, Massarelli G, Banks BM, Rosai J: A systemic lym- phoproliferative disorder with morphologic features of Castleman’s disease. Pathological findings in 15 patients. Am J Surg Pathol 7:211-231, 1983
[5] Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol 24: 76-83, 2012.
[6] Frizzera G, Peterson BA, Bayrd ED, Goldman A: A systemic lymphoproliferative disorder with morphologic features of Castleman's disease : clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216, 1985
[7] Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683, 1972
[8] Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, et al.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995
[9] Lui SL, Chan KW, Li FK, et al. Castle-man's disease and mesangial proliferative glomerulonephritis The role of interleukin-6. Nephron 1998;78:323-7.
[10] Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by momoclonal antiinterleukin-6 antibody. N Engl J Med 1994; 330:602-5.
[11] Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, et al.: Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman’s disease : A clinicopatholoic study of five cases. Pathol Res Pract 193:565-571, 1997
[12] Hattori N, Nakashima H, Usui T, Maeda T, Yanagisawa K, Nakamaki T, Tomoyasu S: Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome. Rinsho Ketsueki. 2007 Dec;48(12):1539-43.
[13] Ozawa T, Kosugi S, Kito M, Onishi M, Kida T, Nakata S, Take H, Katagiri S: efficacy of ritiximab for TAFRO syndrome, a variant type of multicentric castlemans’s disease Rinsho Ketsueki. 2014 Mar;55(3):350-5.
Author Information
  • Internal medicine department, Saint Antoine Hospital, Paris, France

  • Internal medicine department, Saint Camille Hospital, Bry-sur-Marne, France

  • Infectious disease department, Tenon hospital, Paris, France

  • Internal medicine department, Saint Antoine Hospital, Paris, France

  • Internal medicine department, Saint Antoine Hospital, Paris, France

Cite This Article
  • APA Style

    Lynn Antoun Abdo, Clement Philippe Morin, Rocco Paolo Collarino, Jean Paul Cabane, Marc Albert Gatfosse. (2014). First European Case of TAFRO Syndrome Associated with Sjogren Disease. American Journal of Internal Medicine, 2(6), 102-105. https://doi.org/10.11648/j.ajim.20140206.12

    Copy | Download

    ACS Style

    Lynn Antoun Abdo; Clement Philippe Morin; Rocco Paolo Collarino; Jean Paul Cabane; Marc Albert Gatfosse. First European Case of TAFRO Syndrome Associated with Sjogren Disease. Am. J. Intern. Med. 2014, 2(6), 102-105. doi: 10.11648/j.ajim.20140206.12

    Copy | Download

    AMA Style

    Lynn Antoun Abdo, Clement Philippe Morin, Rocco Paolo Collarino, Jean Paul Cabane, Marc Albert Gatfosse. First European Case of TAFRO Syndrome Associated with Sjogren Disease. Am J Intern Med. 2014;2(6):102-105. doi: 10.11648/j.ajim.20140206.12

    Copy | Download

  • @article{10.11648/j.ajim.20140206.12,
      author = {Lynn Antoun Abdo and Clement Philippe Morin and Rocco Paolo Collarino and Jean Paul Cabane and Marc Albert Gatfosse},
      title = {First European Case of TAFRO Syndrome Associated with Sjogren Disease},
      journal = {American Journal of Internal Medicine},
      volume = {2},
      number = {6},
      pages = {102-105},
      doi = {10.11648/j.ajim.20140206.12},
      url = {https://doi.org/10.11648/j.ajim.20140206.12},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.ajim.20140206.12},
      abstract = {We herein describe a case of an unusual multicentric castleman disease(MCD) accompanied by Thrombocytopenia, Anasarca, myeloFibrosis and Renal failure, compatible with TAFRO syndrome and associated with Sjogren disease. The treatment with corticosteroids dramatically improved the symptoms. The clinical features of this case were similar to those reported previously in Japan but this appears to be the first European MCD with negative HHV8 and HIV that meets the criteria of TAFRO syndrome, associated with Sjögren disease.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - First European Case of TAFRO Syndrome Associated with Sjogren Disease
    AU  - Lynn Antoun Abdo
    AU  - Clement Philippe Morin
    AU  - Rocco Paolo Collarino
    AU  - Jean Paul Cabane
    AU  - Marc Albert Gatfosse
    Y1  - 2014/11/20
    PY  - 2014
    N1  - https://doi.org/10.11648/j.ajim.20140206.12
    DO  - 10.11648/j.ajim.20140206.12
    T2  - American Journal of Internal Medicine
    JF  - American Journal of Internal Medicine
    JO  - American Journal of Internal Medicine
    SP  - 102
    EP  - 105
    PB  - Science Publishing Group
    SN  - 2330-4324
    UR  - https://doi.org/10.11648/j.ajim.20140206.12
    AB  - We herein describe a case of an unusual multicentric castleman disease(MCD) accompanied by Thrombocytopenia, Anasarca, myeloFibrosis and Renal failure, compatible with TAFRO syndrome and associated with Sjogren disease. The treatment with corticosteroids dramatically improved the symptoms. The clinical features of this case were similar to those reported previously in Japan but this appears to be the first European MCD with negative HHV8 and HIV that meets the criteria of TAFRO syndrome, associated with Sjögren disease.
    VL  - 2
    IS  - 6
    ER  - 

    Copy | Download

  • Sections